JEE Advanced 2021: No centres abroad this year, foreign candidates can take test in India

-

No foreign examination centres will be alotted for the Joint Entrance Examination (JEE) Advanced this year, as per the Indian Institute of Technology (IIT), Kharagpur. Candidates can view the announcement at the official website http://www.jeeadv.ac.in/.

In its official notification, the institute has stated it will not conduct the JEE (Advanced) 2021 in any foreign centre/country due to the prevailing COVID-19 pandemic. Foreign candidates can appear for the examination at any centre in India, as per their choice, at their own expense. The applicants should adhere to the required travel norms of the Indian government, as well as their countries of residence, before appearing for the test.

The notification also states that candidates who had registered for the JEE (Advanced) 2020 but were absent in either of the papers, could appear for this year’s examination after completing the registration process. The measure is a one-time relaxation offered to candidates.

The measure is also applicable to foreign nationals who had applied for the JEE (Advanced) in 2020. The seats for foreign nationals will be created as supernumerary seats, with a cap of 10 percent of the total seats in the course.

The registration for the JEE (Advanced) 2021 will start from 11 September and go on till 16 September. For the registered applicants, 17 September will be the last day for fee payment. The admit cards will be available for download from 25 September to 3 October.

The exam will be conducted on 3 October, with the provisional answers being out on 10 October. Candidates will be able to provide authorities with the feedback and comments on the provisional key till 5 pm on 11 October.

The final answer keys and the examination results will be declared on 15 October.

The JEE Advanced is conducted for admissions into the IITs and is usually open to the top 2.5 lakh students who have cleared the JEE Mains.



from Firstpost India Latest News https://ift.tt/2WY7sDf
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more